We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Computer Program Predicts Novel Genes

By Biotechdaily staff writers
Posted on 17 Feb 2003
Researchers using a recently developed computer program that predicts novel genes have identified 1,019 previously unrecognized genes that are shared by both the mouse and human genomes. More...
Their findings were published in the February 4, 2003, issue of the Proceedings of the National Academy of Sciences.

"Whereas it might have taken 7,000 experiments to verify a thousand genes, with our method it now will take only about 1,500,” said senior author Dr. Michael R. Brent, associate professor of computer science at Washington University (St. Louis, MO, USA), who developed Twinscan, one of the programs used in the study. Twinscan predicts genes by looking at both the alignment between the two genomes and statistical patterns in the individual DNA sequences of each genome.

In the current study, the researchers employed a two-stage procedure that exploited the mouse and human genome sequences to produce a set of genes with a much higher rate of experimental verification than had been previously reported by other prediction methods. RT-PCR (reverse transcription-polymerase chain reaction) amplification and direct sequencing applied to an initial sample of mouse predictions that did not overlap previously known genes verified the regions flanking one intron in 139 predictions, with verification rates reaching 76%. The investigators verified 112 previously unknown homologs of known proteins, including two homeobox proteins relevant to developmental biology, an aquaporin, and a homolog of dystrophin. They estimated that transcription and splicing could be verified for > 1,000 gene predictions identified by this method that do not overlap known genes.

Dr. Brent said, "We now have this very sensitive and specific method for finding, predicting, and testing multi-exon genes in mammals, and we think that the method provides a very good tool for completing the catalog of multi-exon genes in humans.”



Related Links:
Washington University

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.